Year |
Citation |
Score |
2017 |
Hwangbo C, Lee HW, Kang H, Ju H, Wiley DS, Papangeli I, Han J, Kim JD, Dunworth WP, Hu X, Lee S, El-Hely O, Sofer A, Pak B, Peterson L, et al. Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension. Circulation. PMID 28356442 DOI: 10.1161/Circulationaha.116.025390 |
0.5 |
|
2017 |
Lee HW, Chong DC, Ola R, Dunworth WP, Meadows S, Ka J, Kaartinen VM, Qyang Y, Cleaver O, Bautch VL, Eichmann A, Jin SW. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28232325 DOI: 10.1161/Atvbaha.116.308422 |
0.596 |
|
2016 |
Kechele DO, Dunworth WP, Trincot CE, Wetzel-Strong SE, Li M, Ma H, Liu J, Caron KM. Endothelial Restoration of Receptor Activity-Modifying Protein 2 Is Sufficient to Rescue Lethality, but Survivors Develop Dilated Cardiomyopathy. Hypertension. PMID 27402918 DOI: 10.1161/Hypertensionaha.116.07191 |
0.78 |
|
2014 |
Klein KR, Karpinich NO, Espenschied ST, Willcockson HH, Dunworth WP, Hoopes SL, Kushner EJ, Bautch VL, Caron KM. Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. Developmental Cell. 30: 528-40. PMID 25203207 DOI: 10.1016/J.Devcel.2014.07.012 |
0.696 |
|
2014 |
Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S, Fischer JC, Wang Y, Cleaver O, Qyang Y, Ober EA, Jin SW. Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circulation Research. 114: 56-66. PMID 24122719 DOI: 10.1161/Circresaha.114.302452 |
0.419 |
|
2011 |
Randhawa PK, Rylova S, Heinz JY, Kiser S, Fried JH, Dunworth WP, Anderson AL, Barber AT, Chappell JC, Roberts DM, Bautch VL. The Ras activator RasGRP3 mediates diabetes-induced embryonic defects and affects endothelial cell migration. Circulation Research. 108: 1199-208. PMID 21474816 DOI: 10.1161/Circresaha.110.230888 |
0.383 |
|
2009 |
Dunworth WP, Caron KM. G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 650-6. PMID 19265032 DOI: 10.1161/Atvbaha.109.185066 |
0.766 |
|
2008 |
Dunworth WP, Fritz-Six KL, Caron KM. Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo. Peptides. 29: 2243-9. PMID 18929609 DOI: 10.1016/J.Peptides.2008.09.009 |
0.635 |
|
2008 |
Fritz-Six KL, Dunworth WP, Li M, Caron KM. Adrenomedullin signaling is necessary for murine lymphatic vascular development. The Journal of Clinical Investigation. 118: 40-50. PMID 18097475 DOI: 10.1172/Jci33302 |
0.747 |
|
2007 |
Gibbons C, Dackor R, Dunworth W, Fritz-Six K, Caron KM. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Molecular Endocrinology (Baltimore, Md.). 21: 783-96. PMID 17053041 DOI: 10.1210/Me.2006-0156 |
0.676 |
|
2006 |
Dackor RT, Fritz-Six K, Dunworth WP, Gibbons CL, Smithies O, Caron KM. Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Molecular and Cellular Biology. 26: 2511-8. PMID 16537897 DOI: 10.1128/Mcb.26.7.2511-2518.2006 |
0.692 |
|
Show low-probability matches. |